J&J wins U.S. FDA approval for bladder cancer drug
Reuters India -

Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.

Read this story at

Loading...

Related Articles